Not Yet RecruitingNot Applicable

A Multi-center Prospective Study on the Oncological and Reproductive Outcomes and Quality of Life in Young Woman After Fertility-sparing Treatment of Endometrial Cancer and Endometrial Intraepithelial Hyperplasia

100 participantsStarted 2025-01-15

Plain-language summary

We will investigate the safety and efficiency of fertility-sapring treatment in ypung women witg endometrial cancer and endometrial intraepithelial hyperplasia

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Fertility sparing treatment of EC and EIN. * 18-45 Years old * From start study (Jan 2025 - end study Jan 2028) * All centras in Sweden Exclusion Criteria: * Not English och Swedish speaking

What they're measuring

Relaps of endometrial cancer or EIN after fertility-sparing treatment

Timeframe: from enrollment to 2 years after fertility-sparing treatment

Trial details

NCT IDNCT06745427

SponsorRegion Stockholm

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2028-01-15

Contact for this trial

Charlotta CR Riese, MD, PHD-student

+46703440206 charlotta.riese@ki.se

View on ClinicalTrials.gov More Endometrial Cancer trials